| Leishmaniasis drug discovery: recent progress and challenges in assay development B Zulfiqar, TB Shelper, VM Avery Drug discovery today 22 (10), 1516-1531, 2017 | 217 | 2017 |
| Screening a natural product-based library against kinetoplastid parasites B Zulfiqar, AJ Jones, ML Sykes, TB Shelper, RA Davis, VM Avery Molecules 22 (10), 1715, 2017 | 57 | 2017 |
| Indoleamine 2, 3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma K Asghar, A Farooq, B Zulfiqar, MU Rashid World Journal of Gastroenterology 23 (13), 2286, 2017 | 33 | 2017 |
| Indoleamine 2, 3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis K Asghar, MT Ashiq, B Zulfiqar, A Mahroo, K Nasir, S Murad Experimental and therapeutic medicine 9 (3), 901-904, 2015 | 26 | 2015 |
| Nanomedicine and cancer immunotherapy: focus on indoleamine 2, 3-dioxygenase inhibitors B Zulfiqar, A Mahroo, K Nasir, RK Farooq, N Jalal, MU Rashid, K Asghar OncoTargets and therapy, 463-476, 2017 | 23 | 2017 |
| Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives B Zulfiqar, A Farooq, S Kanwal, K Asghar Frontiers in Pharmacology 13, 1035171, 2022 | 19 | 2022 |
| Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacy AM Thompson, PD O’Connor, AJ Marshall, AF Francisco, JM Kelly, J Riley, ... European journal of medicinal chemistry 207, 112849, 2020 | 18 | 2020 |
| Review of 10 years of research on breast cancer patients: focus on indoleamine 2, 3-dioxygenase K Asghar, A Farooq, B Zulfiqar, A Loya World Journal of Clinical Oncology 12 (6), 429, 2021 | 8 | 2021 |
| Total synthesis of the antimalarial ascidian natural product albopunctatone GA Pullella, AP Wdowiak, ML Sykes, L Lucantoni, KV Sukhoverkov, ... Organic letters 21 (14), 5519-5523, 2019 | 8 | 2019 |
| Assay development in leishmaniasis drug discovery: a comprehensive review B Zulfiqar, VM Avery Expert Opinion on Drug Discovery 17 (2), 151-166, 2022 | 7 | 2022 |
| DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1 S Braillard, M Keenan, KJ Breese, J Heppell, M Abbott, R Islam, ... Science translational medicine 15 (726), eadh9902, 2023 | 4 | 2023 |
| Indoleamine 2, 3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma A Farooq, B Zulfiqar, K Asghar Journal of Cancer & Allied Specialties 9 (1), 2023 | 2 | 2023 |
| Identification and Characterization of Novel Anti-leishmanial Compounds B Zulfiqar Doctoral dissertation, Griffith University), 1-365, 2017 | 1 | 2017 |
| Thieno [3, 2-b] pyrrole 5-carboxamides as potent and selective inhibitors of Giardia duodenalis CJS Hart, AG Riches, S Tiash, R Abraham, K Fayd’Herbe, E Joch, ... International Journal for Parasitology: Drugs and Drug Resistance 23, 54-62, 2023 | | 2023 |
| Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen AF Francisco, G Chen, W Wang, ML Sykes, F Escudié, I Scandale, F Olmo, ... Frontiers in Tropical Diseases 4, 1254061, 2023 | | 2023 |
| Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen AF Francisco, G Chen, W Wang, ML Sykes, F Escudié, I Scandale, F Olmo, ... Frontiers in Tropical Diseases 4, 1254061, 2023 | | 2023 |
| IDENTIFICATION AND BIOLOGICAL CHARACTERIZATION OF NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS OBTAINED FROM HIGH THROUGHPUT SCREENING OF LEISHMANIA PARASITE B Zulfiqar, AJ Jones, TB Shelper, VM Avery AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 95 (5), 162-162, 2017 | | 2017 |
| INDOLEAMINE 2, 3-DIOXYGENASE: POTENTIAL IN CANCER IMMUNOTHERAPY B Zulfiqar, K Asghar A Journal of Science for Development, 33, 2014 | | 2014 |
